Sleep Stack

The Sleep Stack leverages two distinct but complementary pathways to optimise sleep architecture. DSIP directly influences sleep-wake cycles by modulating neurotransmitter activity in the hypothalamus, specifically targeting delta wave sleep phases crucial for physical restoration and memory consolidation. Early research suggests DSIP reduces sleep latency (time to fall asleep) whilst increasing time spent in restorative deep sleep stages.

Ipamorelin complements this through growth hormone pathway activation. Studies demonstrate that growth hormone release peaks during deep sleep, creating a positive feedback loop: better sleep enhances natural GH production, whilst therapeutic GH levels improve sleep quality. Ipamorelin's selective ghrelin receptor activation promotes this cycle without disrupting cortisol patterns that could interfere with sleep.

The timing synergy proves particularly effective. DSIP's rapid onset (15-30 minutes) initiates the sleep cascade, whilst Ipamorelin's 2-3 hour peak aligns with natural GH pulse timing. This combination addresses both sleep induction difficulties and sleep maintenance issues, targeting the complete sleep cycle rather than isolated symptoms. Users report not just faster sleep onset, but more refreshing, consolidated sleep with reduced night-time awakenings.

DSIP Protocol:

• Dose: 100-500mcg per injection
• Timing: 30-60 minutes before desired bedtime
• Method: Subcutaneous injection, rotating injection sites
• Frequency: 5-6 days per week, 2 rest days
• Cycle: 4-6 weeks on, 1-2 weeks off

Ipamorelin Protocol:

• Dose: 200-300mcg per injection
• Timing: 2-3 hours before bed (empty stomach)
• Method: Subcutaneous injection, abdomen or thigh
• Frequency: Daily during sleep optimization phases
• Cycle: 8-12 weeks on, 4 weeks off

Preparation: Both peptides require reconstitution with bacteriostatic water. See our reconstitution guide for detailed mixing instructions. Store reconstituted peptides refrigerated and use within 30 days.

Injection Timing: Take Ipamorelin first (2-3 hours before bed), followed by DSIP 30-60 minutes before sleep. This sequence allows Ipamorelin to initiate GH release whilst DSIP directly promotes sleep onset. Inject on an empty stomach for optimal absorption - avoid food 2 hours before and 1 hour after injection.

Cycle Management: Begin with shorter cycles to assess individual response. Some users benefit from continuous DSIP use with intermittent Ipamorelin cycles, particularly during high-stress periods or seasonal sleep disruptions.

Weeks 1-2: Initial sleep latency improvements typically emerge within 3-5 days. Users report falling asleep 15-30 minutes faster than baseline, with reduced middle-of-the-night awakenings. Some experience vivid dreams as sleep architecture shifts towards deeper phases.

Weeks 3-4: Sleep quality improvements become more pronounced. Morning grogginess decreases as users spend more time in restorative sleep stages. Energy levels during daytime hours typically improve, with many reporting reduced afternoon fatigue.

Month 2: Consolidated improvements in sleep efficiency (time asleep vs. time in bed). Users often report needing slightly less total sleep time whilst feeling more refreshed. Recovery from physical exercise and stress typically accelerates.

Month 3+: Long-term benefits include improved stress resilience, better cognitive function, and enhanced metabolic health markers. Sleep patterns often remain improved even during off-cycle periods, suggesting positive adaptation of natural sleep regulatory mechanisms.

DSIP demonstrates excellent tolerability in most users, with mild drowsiness the following day being the most commonly reported effect during initial weeks. Some users experience intensified dreams or altered dream patterns as sleep architecture changes.

Ipamorelin side effects may include temporary water retention, mild joint discomfort, or increased appetite during the first week. These typically resolve as the body adapts to elevated growth hormone levels.

Contraindications: Individuals with active cancer, severe sleep apnoea, or pregnancy should avoid this stack. Those with diabetes should monitor blood glucose levels closely, as growth hormone can affect insulin sensitivity.

Drug Interactions: May potentiate effects of other CNS depressants. Consult healthcare providers before combining with prescription sleep medications or anxiety treatments.

As with all peptides in the UK, these compounds exist in a regulatory grey area. Review our UK peptide legality guide for current legal considerations and responsible sourcing practices.